Nuclear genetic control of mtDNA copy number and heteroplasmy in humans
Broad Institute · Howard Hughes Medical Institute · +4 more institutions
Abstract
Abstract Mitochondrial DNA (mtDNA) is a maternally inherited, high-copy-number genome required for oxidative phosphorylation 1 . Heteroplasmy refers to the presence of a mixture of mtDNA alleles in an individual and has been associated with disease and ageing. Mechanisms underlying common variation in human heteroplasmy, and the influence of the nuclear genome on this variation, remain insufficiently explored. Here we quantify mtDNA copy number (mtCN) and heteroplasmy using blood-derived whole-genome sequences from 274,832 individuals and perform genome-wide association studies to identify associated nuclear loci. Following blood cell composition correction, we find that mtCN declines linearly with age and is…
Citation impact
- FWCI
- 25.58
- Percentile
- 100%
- References
- 100
Authors
12- RGRahul GuptaCorresponding
Broad Institute, Howard Hughes Medical Institute, Massachusetts General Hospital, Center for Systems Biology
- MKMasahiro Kanai
Broad Institute, Massachusetts General Hospital
- TDTimothy Durham
Broad Institute, Howard Hughes Medical Institute, Massachusetts General Hospital
- KTKristin Tsuo
Broad Institute, Massachusetts General Hospital
- JGJason G. McCoy
Broad Institute, Howard Hughes Medical Institute, Massachusetts General Hospital
Topics & keywords
- Heteroplasmy
- Mitochondrial DNA
- Biology
- Genetics
- Nuclear DNA
- Indel
- Genome
- mtDNA control region
Funding
- HHHoward Hughes Medical Institute
- JCJane Coffin Childs Memorial Fund for Medical Research
- WTWellcome TrustAwards: 212219/Z/18/Z, MR/S005021/1, BRC-1215-20014
- ASAlzheimer's SocietyAward: AS-PG-18b-022
- NINational Institute for Health and Care ResearchAwards: BRC-1215-20014, MR/S005021/1
- LTLeverhulme TrustAwards: MR/S035699/1, RPG-2018-408, BRC-1215-20014, AS-PG-18b-022
- DODepartment of Health and Social Care
- NNNovo NordiskAward: NNF21SA0072102
- NNNovo Nordisk FondenAward: NNF21SA0072102
- NINational Institutes of HealthAwards: OD026553, 3 OT2 OD025315, OT2 OD026551, U24 OD023121, 3 OT2 OD023206, 1 OT2 OD025276, AOD 16037, 1 U24 OD023121, OT2 OD025277, OT2 OD025315, 1 OT2 OD026549, OT2 OD026557, 1 U24 OD023163, 1 OT2 OD026551, 1 OT2 OD026550, 1 OT2 OD 026552, U2C OD023196, OT2 OD 026552, OT2 OD026553, 3 OT2 OD023205, 1 OT2 OD026554, 1 OT2 OD025337, OT2 OD023206, OT2 OD026554, OT2 OD026556, OT2 OD026550, OT2 OD026548, OT2 OD026555, 1 OT2 OD026548, 1 OT2 OD026555, OT2 OD026549, OT2 OD025337, U24 OD023163, 1 OT2 OD026557, 1 OT2 OD026553, 1 OT2 OD025277, OT2 OD025276, U24 OD023176, 5 U2C OD023196, 1 OT2 OD026556, HHSN 263201600085U, 263201600085U, OT2 OD023205
- MRMedical Research CouncilAwards: MR/S035699/1, MR/S005021/1, MR/S035699/1, MR/S005021/1, BRC-1215-20014, MC_UU_00028/7
- NCNIHR Cambridge Biomedical Research CentreAward: BRC-1215-20014